Global Real World Evidence Solutions Market, by Therapeutic Area (Cardiovascular, Oncology, Immunology), by Component (Dataset and Services), by End-User (Medical Devices, Payers, Pharmaceuticals, Providers), by Regional Outlook (U.S., Rest of North America, France, UK, Germany, Spain, Italy, Rest of Europe, China, Japan, India, Southeast Asia, Rest of Asia Pacific, GCC Countries, Southern Africa, Rest of MEA, Brazil, Rest of Latin America) – Market Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2015-2023

2019-10-04
Report Code: BWC19297
Available Format: PDF PDF Icon
Pages: 125

The Global Real World Evidence Solutions Market: Overview

The Global Real World Evidence Solutions Market is projected to grow at a steady rate during the forecast period. Real-world evidence is the clinical proof with respect to the utilization and potential advantages or dangers of a restorative item got from the examination of genuine information. Real-world data (RWD) is characterized as information got from various sources that are related to results in a heterogeneous patient populace in genuine settings. This real-world evidence solutions market will demonstrate quick development because of the move from volume to esteem based consideration, expanding maturing populace and pervasiveness of incessant maladies and postponements in medication advancement and the ensuing increment being developed expenses.

Pharmaceutical organizations take quite a long while to acquaint another medication atom with the market, and they put billions in innovative work with a low likelihood of achievement. To abbreviate the medication improvement cycles, pharma research focuses need a reasonable knowledge on treatment alternatives that work in a wide populace contrasted with couple of patient pools in clinical preliminaries. The utilization of real-world evidence (RWE) bits of knowledge is in this way discovered expanding as pharma and biotech organizations understand that RWE can be significant in medication improvement and life-cycle the board and furthermore increment proficiency in advancement and cost of clinical preliminaries.

The huge pharmaceutical organizations are discovered utilizing a clinico-genomic database with tumor sequencing data for disease revelation studies and focused on medication improvement. Organizations are along these lines ready to widen their sign range and lead few clinical preliminaries for the uncommon biomarker-characterized populace. In this manner, it shows the development of real-world evidence market, during the estimated time frame.

Moreover, this present reality informational collections are broadly embraced by end-clients for RWE for different applications, for example, sedate improvement and endorsements, advertise get to and repayment/inclusion choices, clinical basic leadership, and restorative gadget advancement and endorsements, among others, that aides in the development of the general market.

The Global Real World Evidence Solutions Market: Type Insight

The Global Real World Evidence Solutions Market is segmented on the basis of its therapeutic area, component, end-user, and regional demand. Based on its therapeutic area, the market is segmented into cardiovascular, oncology, immunology. on the basis of its component, the market is segmented into dataset and services. Further, the dataset segment is bifurcated into clinical, pharmacy, claims, patient. based on its end-user, the market is divided into medical devices, payers, pharmaceuticals, providers. Geographically, the Global Real World Evidence Solutions Market is divided into global regions like Europe, North America, Asia- Pacific, Middle East, LATAM, and Africa.

The Global Real World Evidence Solutions Market: Regional Insight

North America is expected to have the largest market share in the global real- evidence management market, owing to the early adoption of technologies and well-established economies in the region. The US is expected to hold the largest market share in North America. Major global real- evidence management market vendors and law enforcement agencies in the US are willing to use global real- evidence management technologies for sharing, storing, and securing the evidence with private companies.

The Global Real World Evidence Solutions Market: Competitive Insight

SAS (US), Syneos Health (US), Anthem (US), Clinigen Group (UK), Palantir Technologies (UK), and Flatiron Health (US),  IQVIA (US), ICON (Ireland), PAREXEL (US), Pharmaceutical Product Development (US), Optum (US), International Business Machines Corporation (US), Cognizant (US), Oracle (US), among others are some of the major players in the Global Real World Evidence Solutions  Market.

The objective of the Study:

·         To analyze and forecast the Global Real World Evidence Solutions market size of the market, in terms of value.

·         To examine the careful market segmentation and forecast the market size, in terms value, based on the region by segmenting the Global Real World Evidence Solutions market into five regions, namely, North America, Europe, Asia Pacific, Middle East, South America and their leading countries.

·         To outline, categorized and forecast the global Real World Evidence Solutions market based on the type and Application.

·         To examine competitive developments like technological advancement, services, and regulative framework within the global Real World Evidence Solutions Market.

·         To highlight the impact analysis of the factors, affecting the market dynamics such as drivers, restraints, opportunities, and challenges.

·         To strategically profile the key players and comprehensively analyze their market shares along with detailing the competitive landscape for market leaders.

Scope of the Report

By Therapeutic Area

·         Cardiovascular

·         Oncology

·         Immunology

By Component

·         Dataset

·         Services

By End-User

·         Medical Devices

·         Payers

·         Pharmaceuticals

·         Providers

Besides, the report provides an analysis of the Global Real World Evidence Solutions market with respect to the following geographic segments:

North America

·         U.S.

·         Rest of North America

Europe

·         France

·         The UK

·         Spain

·         Germany

·         Italy

·         Rest of Europe

Asia Pacific

·         China

·         Japan

·         India

·         Southeast Asia

·         Rest of Asia Pacific

Middle East and Africa

·         Southern Africa

·         Rest of Middle East and Africa

Latin America

·         Brazil

·         Rest of Latin America

Business Questions answer by the report

·         How will the market drivers, restraints and opportunities affect the market dynamics?

·         What will be the market size in terms of value and volume and market statistics with a detailed classification?

·         Which segment dominates the market or region and one will be the fastest growing and why?

·         A comprehensive survey of the competitive landscape and the market participant players

·         Analysis of strategy adopted by the key player and their impact on other players.

Customization Scope for the Client

Client satisfaction is our first and last priority and that’s why BlueWeave Consulting offers customization according to Company’s specific needs. The following customization options are available for the report:

Additional Company Information

·         With five additional company detail analysis

·         Additional country analysis

·         Detailed segment analysis

1.    Research Framework

1.1. Research Objective

1.2. Product Overview

1.3. Market Segmentation

2.    Research Methodology

3.    Executive Summary

4.    Industry Insights

4.1. Industry Impact and Forces

4.1.1.   Growth Drivers

4.1.2.   Challenges

4.1.3.   Trends

4.2. Technology Landscape

4.3. Regulatory Framework

4.4. Company Share Analysis, 2018

4.5. Growth potential Analysis

4.6. Strategic Outlook

4.7. Porter’s analysis

4.8. PESTEL analysis

5.    Global Real World Evidence Solutions Market Overview

5.1. Market Size & Forecast

5.1.1.   By Value (USD Million)

5.2. Market Share & Forecast

5.2.1.   By Therapeutic Area

5.2.1.1.       Cardiovascular

5.2.1.2.       Oncology

5.2.1.3.       Immunology

5.2.2.   By Component

5.2.2.1.       Dataset

5.2.2.2.       Services

5.2.3.   By End-User

5.2.3.1.       Medical Devices

5.2.3.2.       Payers

5.2.3.3.       Pharmaceuticals

5.2.3.4.       Providers

5.2.4.   By Region

5.2.4.1.       North America

5.2.4.2.       Europe

5.2.4.3.       Asia Pacific

5.2.4.4.       South America

5.2.4.5.       Middle East & Africa

6.    North America Real World Evidence Solutions Market Overview

6.1. Market Size & Forecast, 2015-2025

6.1.1.   By Value (USD Million)

6.2. Market Share & Forecast

6.2.1.   By Therapeutic Area

6.2.2.   By Component

6.2.3.   By End-User

6.2.4.   By Country

6.2.4.1.       US

6.2.4.2.       Canada

7.    Europe Real World Evidence Solutions Market Overview

7.1. Market Size & Forecast, 2015-2025

7.1.1.   By Value (USD Million)

7.2. Market Share & Forecast

7.2.1.   By Therapeutic Area

7.2.2.   By Component

7.2.3.   By End-User

7.2.4.   By Country

7.2.4.1.       Germany

7.2.4.2.       UK

7.2.4.3.       France

7.2.4.4.       Italy

7.2.4.5.       Spain

8.    Asia Pacific Real World Evidence Solutions Market Overview

8.1. Market Size & Forecast, 2015-2025

8.1.1.   By Value (USD Million)

8.2. Market Share & Forecast

8.2.1.   By Therapeutic Area

8.2.2.   By Component

8.2.3.   By End-User

8.2.4.   By Country

8.2.4.1.       China

8.2.4.2.       India

8.2.4.3.       Japan

8.2.4.4.       Southeast Asia

9.    Latin America Real World Evidence Solutions Market Overview

9.1. Market Size & Forecast, 2015-2025

9.1.1.   By Value (USD Million)

9.2. Market Share & Forecast

9.2.1.   By Therapeutic Area

9.2.2.   By Component

9.2.3.   By End-User

9.2.4.   By Country

9.2.4.1.       Brazil

9.2.4.2.       Argentina

10. Middle East & Africa Real World Evidence Solutions Market Overview

10.1.             Market Size & Forecast, 2015-2025

10.1.1. By Value (USD Million)

10.2.             Market Share & Forecast

10.2.1. By Therapeutic Area

10.2.2. By Component

10.2.3. By End-User

10.2.4. By Country

10.2.4.1.    Saudi Arabia

10.2.4.2.    UAE

10.2.4.3.    South Africa

11. Company Profile (Company Overview, Financial Matrix, Key Product landscape, Key Personnel, Key Competitors, Contact Address, SWOT Analysis and Strategic Outlook)

11.1.             SAS

11.2.             Syneos Health

11.3.             Anthem

11.4.             Clinigen Group

11.5.             Palantir Technologies

11.6.             Flatiron Health

11.7.             IQVIA

11.8.             ICON

11.9.             PAREXEL

11.10.          Pharmaceutical Product Development

11.11.          Optum

11.12.          International Business Machines Corporation

11.13.          Cognizant

11.14.          Oracle

11.15.          Other Prominent Players

*Financial Details Not Be Captured in Case of Unlisted Companies

The segmentation and the companies are subjected to modifications based on in-depth secondary for the final deliverable